| 摘要 |
It is intended to provide a composition for preventing and/or ameliorating lifestyle-related diseases which contains at least one compound selected fro m the group consisting of glabrene, glabridine, glabrol, 3~-hydroxy-4~-o- methylglabridine, 4~-o-methylglabridine and hispaglabridine, that are compounds having a PPAR.gamma. ligand activity and being efficacious in improving insulin resistance and preventing and/or ameliorating lifestyle- related diseases such as visceral fat obesity, type 2 diabetes, hyperlipemia and hypertension and is usable in foods and drinks (for example, health food s and foods with health claims), drugs, quasi drugs or cosmetics; or a composition for regulating and/or ameliorating body weight gain. |
